Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2013 (2013), Article ID 210563, 9 pages
http://dx.doi.org/10.1155/2013/210563
Research Article

Carbon Monoxide Attenuates Dextran Sulfate Sodium-Induced Colitis via Inhibition of GSK-3β Signaling

1School of Biological Sciences, University of Ulsan, Ulsan 680-749, Republic of Korea
2Department of Thoracic and Cardiovascular Surgery, Affiliated Hospital of Yanbian University, Yanji 133000, China
3Department of Anatomy, School of Medicine, Institute of Health Sciences, Gyeongsang National University, Jinju 660-701, Republic of Korea

Received 17 September 2013; Accepted 9 October 2013

Academic Editor: Alfredo Vannacci

Copyright © 2013 Md. Jamal Uddin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Fiocchi, “Inflammatory bowel disease: etiology and pathogenesis,” Gastroenterology, vol. 115, no. 1, pp. 182–205, 1998. View at Publisher · View at Google Scholar · View at Scopus
  2. R. J. Xavier and D. K. Podolsky, “Unravelling the pathogenesis of inflammatory bowel disease,” Nature, vol. 448, no. 7152, pp. 427–434, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Lawrence, M. Bebien, G. Y. Liu, V. Nizet, and M. Karin, “IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation,” Nature, vol. 434, no. 7037, pp. 1138–1143, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. I. Okayasu, S. Hatakeyama, M. Yamada, T. Ohkusa, Y. Inagaki, and R. Nakaya, “A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice,” Gastroenterology, vol. 98, no. 3, pp. 694–702, 1990. View at Google Scholar · View at Scopus
  5. Y. Yamada, S. Marshall, R. D. Specian, and M. B. Grisham, “A comparative analysis of two models of colitis in rats,” Gastroenterology, vol. 102, no. 5, pp. 1524–1534, 1992. View at Google Scholar · View at Scopus
  6. S. W. Ryter, D. Morse, and A. M. K. Choi, “Carbon monoxide and bilirubin: potential therapies for pulmonary/vascular injury and disease,” American Journal of Respiratory Cell and Molecular Biology, vol. 36, no. 2, pp. 175–182, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. R. A. F. Hegazi, K. N. Rao, A. Mayle, A. R. Sepulveda, L. E. Otterbein, and S. E. Plevy, “Carbon monoxide ameliorates chronic murine colitis through a heme oxygenase 1-dependent pathway,” The Journal of Experimental Medicine, vol. 202, no. 12, pp. 1703–1713, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Z. Sheikh, R. A. Hegazi, T. Kobayashi et al., “An anti-inflammatory role for carbon monoxide and heme oxygenase-1 in chronic Th2-mediated murine colitis,” Journal of Immunology, vol. 186, no. 9, pp. 5506–5513, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Nakao, H. Toyokawa, M. Abe et al., “Heart allograft protection with low-dose carbon monoxide inhalation: effects on inflammatory mediators and alloreactive T-cell responses,” Transplantation, vol. 81, no. 2, pp. 220–230, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Kohmoto, A. Nakao, D. B. Stolz et al., “Carbon monoxide protects rat lung transplants from ischemia-reperfusion injury via a mechanism involving p38 MAPK pathway,” American Journal of Transplantation, vol. 7, no. 10, pp. 2279–2290, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. U. Goebel, M. Siepe, A. Mecklenburg et al., “Carbon monoxide inhalation reduces pulmonary inflammatory response during cardiopulmonary bypass in pigs,” Anesthesiology, vol. 108, no. 6, pp. 1025–1036, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Cepinskas, K. Katada, A. Bihari, and R. F. Potter, “Carbon monoxide liberated from carbon monoxide-releasing molecule CORM-2 attenuates inflammation in the liver of septic mice,” American Journal of Physiology: Gastrointestinal and Liver Physiology, vol. 294, no. 1, pp. G184–G191, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Minamino, H. Christou, C.-M. Hsieh et al., “Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 15, pp. 8798–8803, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Sawle, R. Foresti, B. E. Mann, T. R. Johnson, C. J. Green, and R. Motterlini, “Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages,” The British Journal of Pharmacology, vol. 145, no. 6, pp. 800–810, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Takagi, Y. Naito, K. Uchiyama et al., “Carbon monoxide liberated from carbon monoxide-releasing molecule exerts an anti-inflammatory effect on dextran sulfate sodium-induced colitis in mice,” Digestive Diseases and Sciences, vol. 56, no. 6, pp. 1663–1671, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Ali, K. P. Hoeflich, and J. R. Woodgett, “Glycogen synthase kinase-3: properties, functions, and regulation,” Chemical Reviews, vol. 101, no. 8, pp. 2527–2540, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. R. S. Jope and G. V. W. Johnson, “The glamour and gloom of glycogen synthase kinase-3,” Trends in Biochemical Sciences, vol. 29, no. 2, pp. 95–102, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Frame and P. Cohen, “GSK3 takes centre stage more than 20 years after its discovery,” The Biochemical Journal, vol. 359, no. 1, pp. 1–16, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. B. J. R. Whittle, C. Varga, A. Pósa, A. Molnár, M. Collin, and C. Thiemermann, “Reduction of experimental colitis in the rat by inhibitors of glycogen synthase kinase-3β,” British Journal of Pharmacology, vol. 147, no. 5, pp. 575–582, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. J. F. Ndisang, N. Lane, and A. Jadhav, “Upregulation of the heme oxygenase system ameliorates postprandial and fasting hyperglycemia in type 2 diabetes,” American Journal of Physiology: Endocrinology and Metabolism, vol. 296, no. 5, pp. E1029–E1041, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. T. J. Chambers, J. M. Owens, G. Hattersley, P. S. Jat, and M. D. Noble, “Generation of osteoclast-inductive and osteoclastogenic cell lines from the H-2KbtsA58 transgenic mouse,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 12, pp. 5578–5582, 1993. View at Google Scholar · View at Scopus
  22. V. P. Marques, G. M. Gonçalves, C. Q. Feitoza et al., “Influence of TH1/TH2 switched immune response on renal ischemia-reperfusion injury,” Nephron Experimental Nephrology, vol. 104, no. 1, pp. e48–e56, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. T. S. Blackwell and J. W. Christman, “The role of nuclear factor-κB in cytokine gene regulation,” American Journal of Respiratory Cell and Molecular Biology, vol. 17, no. 1, pp. 3–9, 1997. View at Google Scholar · View at Scopus
  24. M. Martin, K. Rehani, R. S. Jope, and S. M. Michalek, “Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3,” Nature Immunology, vol. 6, no. 8, pp. 777–784, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. F. Demarchi, C. Bertoli, P. Sandy, and C. Schneider, “Glycogen synthase kinase-3β regulates NF-κB1/p105 stability,” The Journal of Biological Chemistry, vol. 278, no. 41, pp. 39583–39590, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. A. M. Badger, J. N. Bradbeer, B. Votta, J. C. Lee, J. L. Adams, and D. E. Griswold, “Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function,” The Journal of Pharmacology and Experimental Therapeutics, vol. 279, no. 3, pp. 1453–1461, 1996. View at Google Scholar · View at Scopus
  27. A. Spittler, M. Razenberger, H. Kupper et al., “Relationship between interleukin-6 plasma concentration in patients with sepsis, monocyte phenotype, monocyte phagocytic properties, and cytokine production,” Clinical Infectious Diseases, vol. 31, no. 6, pp. 1338–1342, 2000. View at Google Scholar · View at Scopus
  28. D. Morse, S. E. Pischke, Z. Zhou et al., “Suppression of inflammatory cytokine production by carbon monoxide involves the JNK pathway and AP-1,” The Journal of Biological Chemistry, vol. 278, no. 39, pp. 36993–36998, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. B. A. Moore, L. E. Otterbein, A. Türler, A. M. K. Choi, and A. J. Bauer, “Inhaled carbon monoxide suppresses the development of postoperative ileus in the murine small intestine,” Gastroenterology, vol. 124, no. 2, pp. 377–391, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. F. A. D. T. G. Wagener, J.-L. Da Silva, T. Farley, T. De Witte, A. Kappas, and N. G. Abraham, “Differential effects of heme oxygenase isoforms on heme mediation of endothelial intracellular adhesion molecule expression,” The Journal of Pharmacology and Experimental Therapeutics, vol. 291, no. 1, pp. 416–423, 1999. View at Google Scholar · View at Scopus
  31. A. Nakao, K. Kimizuka, D. B. Stolz et al., “Carbon monoxide inhalation protects rat intestinal grafts from ischemia/reperfusion injury,” The American Journal of Pathology, vol. 163, no. 4, pp. 1587–1598, 2003. View at Google Scholar · View at Scopus
  32. J. S. Neto, A. Nakao, K. Kimizuka et al., “Protection of transplant-induced renal ischemia-reperfusion injury with carbon monoxide,” American Journal of Physiology: Renal Physiology, vol. 287, no. 5, pp. F979–F989, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Uchiyama, Y. Naito, T. Takagi et al., “Carbon monoxide enhance colonic epithelial restitution via FGF15 derived from colonic myofibroblasts,” Biochemical and Biophysical Research Communications, vol. 391, no. 1, pp. 1122–1126, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Naito, T. Takagi, K. Uchiyama, and T. Yoshikawa, “Heme oxygenase-1: a novel therapeutic target for gastrointestinal diseases,” Journal of Clinical Biochemistry and Nutrition, vol. 48, no. 2, pp. 126–133, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Xia, J. Rao, A. Yao, F. Zhang, G. Li, X. Wang et al., “Lithium exacerbates hepatic ischemia/reperfusion injury by inhibiting GSK-3beta/NF-kappaB-mediated protective signaling in mice,” European Journal of Pharmacology, vol. 697, no. 1–3, pp. 117–125, 2012. View at Publisher · View at Google Scholar
  36. C. Platzer, E. Fritsch, T. Elsner, M. H. Lehmann, H. D. Volk, and S. Prosch, “Cyclic adenosine monophosphate-responsive elements are involved in the transcriptional activation of the human IL-10 gene in monocytic cells,” European Journal of Immunology, vol. 29, no. 10, pp. 3098–3104, 1999. View at Google Scholar
  37. X. Hu, P. K. Paik, J. Chen et al., “IFN-γ Suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 Proteins,” Immunity, vol. 24, no. 5, pp. 563–574, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. Y.-A. Song, Y.-L. Park, K.-Y. Kim et al., “Black tea extract prevents lipopolysaccharide-induced NF-κB signaling and attenuates dextran sulfate sodium-induced experimental colitis,” BMC Complementary and Alternative Medicine, vol. 11, article 91, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. I. Villegas, C. La Casa, A. Orjales, and C. Alarcon de la Lastra, “Effects of dosmalfate, a new cytoprotective agent, on acute and chronic trinitrobenzene sulphonic acid-induced colitis in rats,” European Journal of Pharmacology, vol. 460, no. 2-3, pp. 209–218, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. T. Takagi, Y. Naito, K. Mizushima et al., “Inhalation of carbon monoxide ameliorates TNBS-induced colitis in mice through the inhibition of TNF-α expression,” Digestive Diseases and Sciences, vol. 55, no. 10, pp. 2797–2804, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. K. Sugimoto, A. Ogawa, E. Mizoguchi et al., “IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis,” The Journal of Clinical Investigation, vol. 118, no. 2, pp. 534–544, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. D. J. Berg, N. Davidson, R. Kühn et al., “Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) Th1-like responses,” The Journal of Clinical Investigation, vol. 98, no. 4, pp. 1010–1020, 1996. View at Google Scholar · View at Scopus
  43. L. Dugo, M. Collin, D. A. Allen et al., “GSK-3β inhibitors attenuate the organ injury/dysfunction caused by endotoxemia in the rat,” Critical Care Medicine, vol. 33, no. 9, pp. 1903–1912, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. P. Cohen and S. Frame, “The renaissance of GSK3,” Nature Reviews Molecular Cell Biology, vol. 2, no. 10, pp. 769–776, 2001. View at Publisher · View at Google Scholar · View at Scopus
  45. C. Hofmann, N. Dunger, J. Schölmerich, W. Falk, and F. Obermeier, “Glycogen synthase kinase 3-β: a master regulator of toll-like receptor-mediated chronic intestinal inflammation,” Inflammatory Bowel Diseases, vol. 16, no. 11, pp. 1850–1858, 2010. View at Publisher · View at Google Scholar · View at Scopus